The controversy of peri-operative ß-blockade: What should i do?

European Journal of Vascular and Endovascular Surgery

Volumn 47, Issue 2, 2014, Pages 119-123

  Priebe, H J ^a  

^a NONE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; LANDIOLOL; METOPROLOL;

ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; CORONARY ARTERY DISEASE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEART SURGERY; HUMAN; ISCHEMIC HEART DISEASE; MORTALITY; PERIOPERATIVE PERIOD; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK ASSESSMENT; STRESS ECHOCARDIOGRAPHY; UNITED KINGDOM;

ADRENERGIC BETA-ANTAGONISTS; DRUG ADMINISTRATION SCHEDULE; EVIDENCE-BASED MEDICINE; HUMANS; META-ANALYSIS AS TOPIC; PATIENT SELECTION; PERIOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; PRACTICE GUIDELINES AS TOPIC; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME;

EID: 84893665143     PISSN: 10785884     EISSN: 15322165     Source Type: Journal    
DOI: 10.1016/j.ejvs.2013.11.005     Document Type: Article

References (30)

1. S. Bouri, M.J. Shun-Shin, G.D. Cole, J. Mayet, and D.P. Francis Meta-analysis of secure randomised controlled trials of β-blockade to prevent perioperative death in non-cardiac surgery Heart 0 2013 1 9 10.1136/heartjnl-2013-304262
2. D. Poldermans, E. Boersma, J.J. Bax, I.R. Thomson, L.L.M. van de Ven, J.D. Blankensteijn The Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery N Engl J Med 341 1999 1789 1794
3. M. Dunkelgrun, E. Boersma, O. Schouten, A.W. Koopman-van Gemert, F. van Poorten, J.J. Bax Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group Bisoprolol and fluvastatin for the reduction of perioperative cardiac mortality and myocardial infarction in intermediate-risk patients undergoing noncardiovascular surgery: a randomized controlled trial (DECREASE-IV) Ann Surg 249 2009 921 926
4. D. Poldermans, J. Bax, E. Boersma, S. De Hert, E. Eeckhout, and G. Fowkes et al. Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery: The Task Force for Preoperative Cardiac Risk Assessment and Perioperative Cardiac Management in Non-cardiac Surgery of the European Society of Cardiology (ESC) and endorsed by the European Society of Anaesthesiology (ESA) Eur Heart J 30 2009 2769 2812
5. L.A. Fleisher, J.A. Beckman, K.A. Brown, H. Calkins, E.L. Chaikof, and K.E. Fleischmann et al. 2009 ACCF/AHA focused update on perioperative beta blockade incorporated into the ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Circulation 120 2009 e169 e276
6. S. Bangalore, J. Wetterslev, S. Pranesh, S. Sawhney, C. Gluud, and F.H. Messerli Perioperative β blockers in patients having non-cardiac surgery: a meta-analysis Lancet 372 2008 1962 1976
7. J. Higgins, and S. Green Cochrane handbook for systematic reviews of interventions version 5.0.0 edn 2008 The Cochrane Collaboration Oxford
8. P.J. Devereaux, H. Yang, S. Yusuf, G. Guyatt, K. Leslie, and J.C. Villar et al. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial Lancet 371 2008 1839 1847
9. POBBLE Trial Investigators Perioperative ß-blockade (Pobble) for patients undergoing infrarenal vascular surgery: results o a randomized double-blind controlled trial J Vasc Surg 41 2005 602 609
10. D.N. Wijeysundera, M. Mamdani, A. Laupacis, L.A. Fleisher, W.S. Beattie, and S.R. Johnson et al. Clinical evidence, practice guidelines, and ß-blocker utilization before major noncardiac surgery Circ Cardiovasc Qual Outcomes 5 2012 558 565
11. M.J. London, K. Hur, G.G. Schwartz, and W.G. Henderson Association of perioperative β-blockade with mortality and cardiovascular morbidity following major noncardiac surgery J Am Med Assoc 309 2013 1704 1713
12. J.G. Baker The selectivity of β-adrenoceptor antagonists at the human β1, β2 and β3 adrenoceptors Br J Pharmacol 144 2005 317 322
13. T.E. Ragoonanan, W.S. Beattie, C.D. Mazer, A.K. Tsui, H. Leong-Poi, and D.F. Wilson et al. Metoprolol reduces cerebral tissue oxygen tension after acute hemodilution in rats Anesthesiology 111 2009 988 1000
14. M.H. El Beheiry, S.P. Heximer, J. Voigtlaender-Bolz, C.D. Mazer, K.A. Connelly, and D.F. Wilson et al. Metoprolol impairs resistance artery function in mice J Appl Physiol 111 2011 1125 1133
15. T. Hu, W.S. Beattie, C.D. Mazer, H. Leong-Poi, H. Fujii, and D.F. Wilson et al. Treatment with a highly selective ß1 antagonist causes dose-dependent impairment of cerebral perfusion after hemodilution in rats Anesth Analg 116 2013 649 662
16. C. Ashes, S. Judelman, D. Wijeysundera, G. Tait, C.D. Mazer, and G.M.T. Hare et al. Selective ß1-antagonism with bisoprolol is associated with fewer postoperative strokes than atenolol or metoprolol: a single-center cohort study of 44,092 consecutive patients Anesthesiology 119 2013 777 787
17. G.A. Mashour, M. Sharifpour, R.E. Freundlich, K.K. Tremper, A. Shanks, and B.K. Nallamothu et al. Perioperative metoprolol and risk of stroke after noncardiac surgery Anesthesiology 119 2013 1340 1346
18. A. Sezai, K. Minami, T. Nakai, M. Hata, I. Yoshitake, and S. Wakui et al. Landiolol hydrochloride for prevention of atrial fibrillation after coronary artery bypass grafting: new evidence from the PASCAL trial J Thorac Cardiovasc Surg 141 2011 1478 1487
19. M.J. Bijl, L.E. Visser, R.H.N. van Schaik, J.A. Kors, J.C.M. Witteman, and A. Hofman et al. Genetic variation in the CYP2D6 gene is associated with a lower heart rate and blood pressure in β-blocker users Clin Pharmacol Ther 85 2008 45 50
20. M.D. Kertai, M. Fontes, and M.V. Podgoreanu Pharmacogenomics of beta-blockers and statins: possible implications for perioperative cardiac complications J Cardiothorac Vasc Anesth 26 2012 1101 1114
21. T. Nozawa, M. Taguchi, K. Tahara, Y. Hashimoto, N. Igarashi, and M. Nonomura et al. Influence of CYP2D6 genotype on metoprolol plasma concentration and β-adrenergic inhibition during long-term treatment: a comparison with bisoprolol J Cardiovasc Pharmacol 46 2005 713 720
22. T. Rau, H. Wuttke, L.M. Michels, U. Werner, K. Bergmann, and M. Kreft et al. Impact of the CYP2D6 genotype on the clinical effects of metoprolol: a prospective longitudinal study Clin Pharmacol Ther 85 2009 269 272
23. W.J. Flu, J.P. van Kuijk, M. Chonchol, T.A. Winkel, H.J. Verhagen, and J.J. Bax et al. Timing of pre-operative beta-blocker treatment in vascular surgery patients: influence on post-operative outcome J Am Coll Cardiol 56 2010 1922 1929
24. C. Ellenberger, G. Tait, and W.S. Beattie Chronic β blockade is associated with a better outcome after elective noncardiac surgery than acute β blockade: a single-center propensity-matched cohort study Anesthesiology 114 2011 817 823
25. W.S. Beattie, D.N. Wijeysundera, K. Karkouti, S. McCluskey, G. Tait, and N. Mitsakakis et al. Acute surgical anemia influences the cardioprotective effects of beta-blockade: a single-center, propensity-matched cohort study Anesthesiology 112 2010 25 33
26. Y. Le Manach, G.S. Collins, C. Ibanez, J.P. Goarin, P. Coriat, and J. Gaudric et al. Impact of perioperative bleeding on the protective effect of β-blockers during infrarenal aortic reconstruction Anesthesiology 117 2012 1203 1211
27. R.B. Weiskopf, M.K. Viele, J. Feiner, S. Kelley, J. Lieberman, and M. Noorani et al. Human cardiovascular and metabolic response to acute, severe isovolemic anemia J Am Med Assoc 279 1998 217 221
28. G.M. Hare, J.M. Worrall, A.J. Baker, E. Liu, N. Sikich, and C.D. Mazer ß2 adrenergic antagonist inhibits cerebral cortical oxygen delivery after severe haemodilution in rats Br J Anaesth 97 2006 617 623
29. http://www.escardio.org/about/press/press-releases/pr-13/Pages/ Statement-Perioperative-Guidelines.aspx [accessed 14.11.13].
30. http://www.escardio.org/about/press/press-releases/pr-13/Pages/ joint-statement-perioperative-guidelines.aspx [accessed 14.11.13].